Literature DB >> 18929732

Forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate.

Luciana Sanches1, Nadia M Marchi, Sara Castro, Cassia Teatin Juliato, Marina Villarroel, Luis Bahamondes.   

Abstract

BACKGROUND: The aim of the study was to compare the bone mineral density (BMD) of postmenopausal women who had used depot-medroxyprogesterone acetate (DMPA) or a copper intrauterine device (IUD) as a comparison group until menopause. STUDY
DESIGN: BMD was measured using dual-energy X-ray absorptiometry at the nondominant forearm for up to 3 years following menopause in 135 women aged 43-58 years: 36 former DMPA users and 99 former IUD users.
RESULTS: Mean duration of use was (mean+/-SEM) 9.4+/-3.8 and 14.7+/-6.2 years for the DMPA and IUD groups, respectively. One year after menopause, mean distal radius BMD was 0.435 and 0.449 in DMPA and IUD users, respectively, and 0.426 and 0.447 at 2-3 years following menopause. Ultra-distal BMD was 0.369 and 0.384 in DMPA and IUD users, respectively, at 1 year, and 0.340 and 0.383 at 2-3 years.
CONCLUSIONS: At 1 and 2-3 years following menopause, no significant differences were observed in the BMD of postmenopausal women aged 43-58 years, who had used DMPA or an IUD until menopause.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18929732     DOI: 10.1016/j.contraception.2008.07.013

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  2 in total

Review 1.  Update on hormonal contraception and bone density.

Authors:  Michelle M Isley; Andrew M Kaunitz
Journal:  Rev Endocr Metab Disord       Date:  2011-06       Impact factor: 6.514

2.  Bone mineral density in midlife long-term users of hormonal contraception in South Africa: relationship with obesity and menopausal status.

Authors:  Mags E Beksinska; Immo Kleinschmidt; Jenni A Smit
Journal:  Womens Midlife Health       Date:  2018-04-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.